Want to join the conversation?
$NVDA's operating expenses for 3Q15 included $8MM of restructuring and other charges. The company expects to incur additional restructuring charges to operating expense of $25-35MM in 4Q16. These restructuring activities will impact approx. 5% of the global workforce, and $NVDA expects them to be substantially completed by FY16-end.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?